Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Lynx Therapeutics enters partnership to identify diabetes-associated SNPs

Aug. 22, 2000

Avanir forms subsidiary to exploit human MAb technology

Aug. 21, 2000

McGill University licenses fungal genomics technology to Mycota Biosciences

Aug. 21, 2000

Anadys signs antifungal collaboration with Pharmacia

Aug. 21, 2000

Screening method based on spectral data offered by NIH for licensing

Aug. 18, 2000

Atrix to use drug delivery technology to develop products for Pfizer

Aug. 17, 2000

Researchers discover protein required for protein translocation in bacteria

Aug. 17, 2000

Isis Pharmaceuticals division to work with R.W. Johnson on antisense target validation

Aug. 16, 2000

Phase II SBIR grant awarded to Aastrom Bioscience for dendritic cell immunotherapy research

Aug. 16, 2000

Newly discovered protein determines cell morphology

Aug. 16, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...